News

Tempus AI has announced that it is using the TIME Network to support Phase I trials and expedite site activation and ...
Nexalin Technology (NXL), announced the completion and launch of phases one through five of its proprietary virtual clinic and digital research ...
SAN ANTONIO, May 1, 2025 /PRNewswire/ -- Summit Clinical Research, LLC ("Summit"), a leading ... of key senior leaders to drive the next phase of Summit's growth. Dr. Naim Alkhouri, MD, FAASLD ...
This milestone builds upon phase one of the virtual clinic ... we can now facilitate clinical research on the HALO™ device while preparing for broader patient adoption. By creating a seamless ...
core cohort dose-limiting toxicity observation period in its ongoing Phase 1b/2a clinical trial. Following a review of safety and efficacy data, the Safety Review Committee (SRC) has approved dose ...